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Franz Sugarman
A major obstacle which I have had to deal
with both as I wrote this paper and designed my
exhibit was the question, "who is this
for?"
Five people will have to read and approve
this paper. Five people had to view and judge
my exhibit. Many more may wish to read my
paper and review the pieces from my exhibit in
orderto decidewhetherto hire me or not. There
FOREWORD
really understand the scientific theory, despite
my best efforts. I cannot cover several years of
premedical andmedical education which I have
not even had myself in this paper. I hope the
person with minimal medical knowledge will be
able to comprehend the fundamental theory
behind the biological basis of schizophrenia.
Non-artists may not be interested in my
are many more people who saw my exhibit, as discussion of the media I chose.
well.
So, who was my exhibit for? Was it for the
general public? Was it for my art professors?
Was it for my science advisor? Was it for my
prospective employers?Was it forthe dean and
assistant dean?
What I had to write about had to cover a
wide range of material in what are effectively
several different languages.
Few of the people who read this paper will
Artists and non-artists alike, who do not use
computers, may have little interest in my
discussion of the computer software I used.
I hope that there will be something for
everyone who reads this paper, however. I
would like to think the discussion of the broader
societal and philosophical questions that the
phenomenon ofmental illness raises, contained
in Part I, will be of interest to all parties. If not,
you have my permission to skip it.
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PARTI
Schizophrenia is a disease that manifests
itself in the victim's behavior. The only means
we have to know of another person's thoughts
and feelings are by way of language and
observation of behavior. Behaviorand language
(which is really a part of behavior) are the only
evidence any of us have that anyone else has
a
"mind"
or a
"self" in the same sense that each
of us believes we possess one of our own. We
all tend to feel responsible for our own actions
and our own behavior, so it's very difficult to
understand how someone else could not be.
Yet, all of us at some time or other have
experienced some form of intoxication and we
can all attest to how it can make us feel and
behave abnormally. Intoxication, furthermore,
is obviously a physical phenomenon with
behavioral consequences.
It may also be useful to recall the dream-
state. When we're dreaming, we often have the
sense of being ourselves but perhaps with a
different appearance or name or set of
memories. I have regular dreams in which I am
Captain Kirk of the starship, Enterprise. Can I
say that under these circumstances, I am the
same person? This may help us to understand
what happens in the mind of the schizophrenic
patient.
There are obvious precedents forthe impact
of physiology and physical phenomena on
human behavior and personality and thus
whatever it is we are referring to when we say,
"mind". Furthermore, neither is what we call the
"self" inviolable. When I referto the "self", I think
we all conjure up roughly the same associations.
"Self" is a certain continuity wp feel from one
moment to the next, or a reference point for a
set of experiences that cannot be shared
identically with anyone else. That reference
point, however, is always changing with the
accumulation of new experiences and feelings
affecting our points-of-view. Can we really say
that from one moment to the next with that
point-of-view ever changing, however subtly,
that we are the same people? Is the self that
exists in one fraction of an instant really any less
distinct from the self in the next fraction of an
instant than from the person next to you?
I think that all this is important to think about
not because any of these questions are
answerable, but because they undermine many
conventions in the way we think about the
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human mind. Those conventions allow us to
think in a kind of shorthand which allows us to
cope with reality on a day to day basis but may
actually impede us from looking at schizophrenia
a trillion neurons \ the human brain is complex
enough to leave plenty of room for all the
mysteries and intricacies and spontaneity of
human behavior. Some people may consider it
from all the angles. In the same sense, we may depressing to think that there might be nothing
all concur that the world is round (a notable
exception being the Flat Earth Society), but in
more to us than our bodies. My experience,
however, is that the more I understand about
our own neighborhoods, up is still up and down the functioning of the human body, the more
is still down - we deal with the Earth on a day to awestruck I am with its complexity. If it's mystery
day basis as if it was flat. that we need to surround ourselves with, then
I believe we are all inclinedto start with a set that complexity should provide us with enough
of preconceptions which tend to prevent a mystery to satisfy us for millenia to come.
complete exploration of the phenomenon of
schizophrenia.
The "self" is a unit of identification , concerned
less with motivation (the "mind") than with
Let us consider several questions with the subjective experience. What I would like to
intention of proposing an alternative view of suggest concerning the
"self" is that what we
individuality with regard to mental illness:
(1) What is the motivating force of human
behavior, or how can it best be explained?
(2) What constitutes the "self"?
(3) When is a person "responsible" or "not
responsible"?
I would like the reader, notwithstanding his
or her religious beliefs, to assume forthe duration
normally consider the unit of the
"self"
can be
further subdivided into units which can function
as
"selves" in isolation from the rest of the "self".
In other words, a person is actually a complex
of different personalities drawing on the same
set of experiences. Each section of the brain
has its own personality which it contributes to
the whole, but which also is peculiarto itself. In
ofthispaperthatall human behavior is a product turn, each neural circuit contributes its
of the neurochemical and neurobiological and
physiological interactions between the human
personality to that section of the brain and each
neuron lends its personality to its neural circuit.
brain and the environment. With approximately Every brain is a community of sorts.
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Research of the different hemispheres of to the cerebral cortex whereas the latter are
the brain and studies of people who have had
their corpus callosi cut (the corpus callosum is
part of the basal nuclei and midbrain.
Furthermore, another area of the cerebralcortex,
thepartofthebrainwhichallowscommunication the prefrontal cortex, is credited with initiating
between the hemispheres of the brain) has complex, premeditated activities. I mention all
shown that sometimes these people exhibit this to demonstrate that there is no single point
contradictory behavior by the different sides of of the brain which initiates all activity or which
theirbodiescontrolledbythecontralateralsides consolidates all experience. There is no
of their brains. The classic example is of a man
who in anger attempted to strike his wife with his
right hand only to have it intercepted by his left.
Besides this lateralization, the brain is subdivided
subdivision of the brain that we can identify as
more
"self"
than any other.
Whatwe think of as ourselves is the interplay
of all these subdivisions of the brain, yet we
further into different areas by structure and cannot simply think of the whole brain as
function (although a structure may not comprising a unified "self". If you remove a
necessarily be devoted to its one own exclusive
function -there may be considerable integration)
and several of these areas may be responsible
particular part of the brain, you will lose that part
of the person and that part of the
"self"
and its
experience, but there will still be a person there
for varying kinds of motivation. The amygdala, who will continue to perceive a continuity of
the caudate nuclei, and the cingulate gyri all "self".
play roles in emotional response and they occur
on both sides of the brain. Therefore, there are
six separate areas of the brain involved in the
Whether the motivating force for human
behavior is biochemical or something else
makes little difference in my opinion. The
generation of emotion - maybe more. How important thing is that human behavior is
separate and distinct they are has not been governed by cause and effect relationships. If
ascertained for certain. The point is that there the self is as tenuous an entity as I've been
are several different sites. The cingulate gyri describing, it further undermines the notions of
are further distinguished from the amygdala
"responsibility"
and "free will". "Responsibility"
and caudate nuclei insofar astheformerbelong implies the existence of a
"self"
and "free will".
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I believe that on a day to day basis, it may make
sense to believe in these concepts, but when
seeking to understand the plight of the mentally
ill, these concepts must be dismissed as illusory.
If we look at ourselves and everything around
us from the perspective I've been describing,
an agent of evaluation and oppression for the
rest of society. Szasz and his compatriots,
however, argued that there is no such thing as
insanity, andthatthereisonlythis judgment, as
if there were no mentally ill in need of help,
whatsoever - that the psychiatric community is
we must dismiss our own senses of merely an alternative police force, preening
"responsibility"
and "free
will"
as unsupportable society of its undesirable elements 2.
concepts, yet our relationships with each other
and our daily experiences of life are built on
these concepts. It would be impossible to live
Again, they are right, in the purest sense.
No one is any more responsible for his own
behavior than anyone else, and no one,
life in daily terms without the concepts of objectively speaking, has any greater hold on
"individuality", "self", "responsibility", or "free reality than anyone else (which undermines
will". Therefore, the issue of whether someone everything I've been saying if you think about it,
is
"responsible"
or "not
responsible"is a matter since I have been assuming all along that my
of judgment or social consensus, just as the viewof reality is the only correct one). There are
label "insane" has always been. Though no one obviously people, however, who will not be able
is truly
"responsible" for his own behavior in to take care of themselves if left to their own
pure terms, there are clearly some people in devices, or who will cause harm to themselves
society who cannot be considered
"responsible"
for their own actions even in the sense that we
allow for the rest of us. There is also, however,
or others if no attempt is made to help them.
Psychiatry and neurology are helping us more
and more to understand the biological basis for
a large unavoidable gray area created by this human behavior and how it can be influenced
societal judgment that has great potential for pharmacologically. They are sciences like any
abuse. Thomas Szasz warned us that it is other with equal potentials for use and abuse.
possible forthe psychiatric community to act as
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PART II
While neuroscience and psychiatric
medicine have made great advances in the
understanding and treatment of mental illness,
aconsensus has not yet formed around a single
unifying theory about the origins of
schizophrenia. The advent of neuroleptic
antipsychotic drugs and their dramatic though
limited success in the treatment of schizophrenia
has helped to establish beyond question that
schizophrenia is adisease of definite physiologic
origins. What those origins are, however, has
remained elusive. There are many fascinating
and diverse theories, each accompanied by its
own supporting body of evidence which often
cannot be replicated by other researchers, to
the frustration of all parties concerned.
Over the course of the last century,
schizophrenia - formerly known as dementia
praecox - has eluded definition. At times it is
referred to as "the
schizophrenias"because
there are several kinds which may not in fact be
related. There appearto be three common sets
of symptoms. The first are the "positive
symptoms", consisting of hallucinations,
delusions, agitation and tension, paranoia,
disorganized thinking and insomnia 3. Second
are the "negative symptoms", consisting of
amotivation, poor social skills, inability to
experience pleasure (anhedonia), limited
spontaneous conversation (alogia), poverty of
speech, reduced expressiveness, and poor
grooming orhygiene4.Thethird, lessfrequently
acknowledged set of symptoms is bizarre,
repetitive behavior, such as insatiable thirst
(polydipsia), hoarding, pacing, etc 5.
"The
schizophrenias"
have been
categorized into "paranoid", "hebephrenic",
"catatonic", "disorganized", "undifferentiated",
and
"residual"
6. They are alternately categorized
by the predominance of either
"positive"
or
"negative"
symptoms. "Type
I"
schizophrenia is
dominated by positive symptoms, tends to occur
later in the patient's life, and usually responds
well to neuroleptic treatment 7. "Type
II"
schizophrenia is dominated by negative
symptoms, tends to have a somewhat earlier
age of onset, and has a worse prognosis 8. The
typical age of onset for schizophrenia is between
the ages of seventeen and twenty-eight 9.
There have been numerous studies of the
brain in schizophrenia based on post mortem
dissection, and electroencephalogram (EEG)
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readings, as well as various newer imaging
systems such as CAT scans, computed
tomography (CT), positron emission
patients studied shortly after onset of symptoms
". This strongly suggests that schizophrenia is
the result of a complication of normal
tomography (PET), and magnetic resonance development brought on by an
earlier- perhaps
imaging (MRI). Some of what appear to be the embryologic
- insult to the brain <e.
more consistent results are: (1 ) in comparisons For the purposes of my exhibit, I did not
of monozygotic twins discordant for concern myself with the distinctions between
schizophrenia, the ventricles of schizophrenic
patients - especially the left lateral horn - are
enlarged compared to their normal twin,
paranoid, hebephrenic, and disorganized
schizophrenia, since in all probability and
according to the best of anyone's knowledge
indicating probable tissue loss somewhere in they are closely related. The main thrust of my
the brain, most likely in the limbic regions or exhibit was based on a theory presented by Dr.
temporal lobes (Fig. 1) ,0; (2) hypoactivity of
glucose metabolism in the dorsolateralprefrontal
Daniel R.Weinberger of the National Institute of
Mental Health as presented in the article,
cortex ,1; (3) reduced hippocampal volume "Implications of Normal Brain Development for
compared to control subjects (Fig. 2) ,2; (4) the Pathogenisis of
Schizophrenia"
as it
increased concentrations of D2 receptors in
various limbic regions ,3; (5) more recently,
disoriented neurons in the hippocampus " and
entorhinal cortex ,5; (6) and some less consistent
irregularities in the temporal region such as
temporal lobe hyper- and hypoactivity, and
diminished temporal lobe gray matter, as well
appeared in the July, 1 987 issue of the journal,
Archives of General Psychiatry.
It has been clear for some time that there is
a relationship between the positive and negative
symptoms of schizophrenia, since they always
occur together, albeit in varying proportions.
What that relationship is, however, has been
as reduced parahippocampal gyrus volume particularly baffling to researchers, especially
compared to control subjects(Fig. 1) ,6.
Also significant is what has not been found
- namely, gliosis and other signs of recent tissue
since the positive symptoms would suggest
limbic hyperactivity andthe negative symptoms
suggest prefrontal hypoactivity - seemingly
damage, even in the case of schizophrenic contradictory conditions. Accommodating these
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Right Temporal Lobe
= 8
Caudate Nuclei
Posterior Horn of
Left Lateral Ventricle
Left Temporal Lobe
Horizontal Section through Human Brain
(Fig. 1) Posterior Horn of
Lateral Ventricle
Amygdaloid Region
Hippocampus
Entorhinal Cortex Parahippocampal Gyrus
Sagital Section through Human Brain
(Fig. 2)
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two apparently disparate sets of symptoms to to
various limbic and midbrain areas along the
one another has been one of the greatest way. For the purposes
of my illustrations, I
challenges for schizophrenia researchers. adapted illustrationsofA10
pathways in monkey
Dr. Weinberger made the most coherent brains from a study by Dr. Dave L. Felton and
attempt to relate the positive and negative John R. Sladek,
Jr.20
symptoms to one another in any theory I had Weinberger and colleagues
theorized -
encountered up to the point that I presented my based on evidence
presented by Pycock, et al,
exhibit. Since then, I have encountered other that rats with lesions of the prefrontal cortex
theories presented in other articles which also exhibited limbic hyperactivity
2' - that a lesion of
begin to deal with this problem and are more
detailed than Dr. Weinberger's 1 987 article. Dr.
Weinberger himself was involved in writing a
the portion of the A10 tract that supplies the
dorsolateralprefrontal cortex or any other lesion
or dysfunction of the dorsolateralprefrontal
couple of these articles, and so has, in fact, cortex would cause limbic hyperactivity in
updated his own theory.
The basic premise of Dr. Weinberger's
original theorywas that some kind of interruption
humans (Fig. 3)22. They theorized that the
dorsolateralprefrontal cortex would normally
exercise an inhibiting effect either on the limbic
of the A10 dopaminergic neural tract of the areas directly or on the ventral tegmental area
brain prevented dopaminergic stimulus of the
dorsolateralprefrontal cortex which, in addition
to being responsible for schizophrenic negative
symptomatology, also resulted in a failure of
that region of the brain to inhibit the limbic areas
which would in turn reduce dopaminergic stimuli
to the limbic and midbrain regions (Fig. 4)23.
Because the dorsolateralprefrontal cortex
isthe region of the human brain associated with
its highest rational functions, a lesion resulting
whose hyperactivity is commonly blamed for in its dysfunction would serve to explain
positive symptomatology ,9. The A10
dopaminergic tract has not been mapped in
schizophrenia's negative symptoms 2J.
Meanwhile, hippocampal and thalamic
humans, but is believed to run from the ventral dopaminergic hyperactivitywould helpto explain
tegmental area of the diencephelon to the the delusions, hallucinations, and occasional
dorsolateralprefrontal cortex and to branch off sensory overload experienced by
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2 A) Lack of stimulus results in
negative symptoms such as
decreased initiative andself
motivation.
impaired reasoning ability.
and unresponsiveness
B) Decreasedstimulus to
pre-frontal corticalareas
results in decreased stimulus
to dependent areas of the brain
1 Interruption ot
dopaminergic
simulus due to
tumor growth,
interrupted blood How
pennatal trauma
demyelim/ation.
or viral infection
etcetera
(Fig. 3)
Dorso-Lateral
Pre-Frontal Cortex
Integration and response
to stimulus via adrenergic,
GABAergic.and other
neurotransmitter pathways
(Thesepathways have not
been specificallymapped)
Ventral
Tegmental
Area
(Fig. 4)
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Dorbo-La Iera I
Pre-Frontal Corte
fhe increase in and/oi more erratic, nature ot sensory input
to the rest ot the brain from the thalamusmanifests itself
m the patient's behavioras hallucination and delusion
schizophrenics, since those regions - especially
thethalamus- normally regulate sensory stimuli
to the brain (Fig. 5)?\ Dopaminergic hyperactivity
of other midbrain and limbic areas such as the
amygdala, nucleus accumbens, and especially
the cingulate gyrus, could explain the emotional
difficulties experienced by schizophrenic
patients (Fig. 6)"
The nature of the lesion of the A10 tract or
dorsolateralprefrontal cortex might ultimately
be important to the treatment of the individual
patient's condition, but it is not important to our
understanding of the basic disorder The lesion
could be caused by something as simple as
diminished blood flow to the region in question,
a tumor, a genetic imperfection, trauma, or a
virus -". Alternatively, it could be the result of a
change in expression of dopamine receptors on
the neurons of the dorsolateralprefrontal cortex
resulting in insensitivity of that region to
dopaminergic stimulus (Fig. 7)M. This change in
expression of dopamine receptors could be the
product of genetics or an auto-immune reaction
to one's own dopamine receptors 29. The
important consequence of all these conditions
is that the dopaminergic stimulus to the
dorsolateralprefrontal cortex would be
obstructed.
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Dorso-Lalerai
Pre-Frontal Cortex
Together, the hallucinations and delusions described
m 5 and the erratic emotionalbehavior descnbed in 6
are referred to as the "positivesymptoms"of Schizophrenia
(Fig. 6)
2 A) Lack ofstimulus results In
negative symptoms such as
decreased initia live and self-
motivation.
impaired reasoning ability.
andunresponsiveness
B) Decreasedstimulus to
Pre-Frontal Corticalareas
results in decreased stimulus
todependent areas of the brain
O Receptoranomaly ii
the cortical tissues
may result in reduced
sensitivity of those areas
lo dopaminergic stimuli
(Fig- 7)
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Neuroleptics function by blocking the
dopamine receptors on those regions of the
brain associated with the positive symptoms of
schizophrenia, such as the thalamus and
cingulate gyrus (Fig. 8)30. They do not distinguish
between these receptors and dopamine
receptors on the rest of the brain and so may
exacerbate negative symptoms somewhat by
blocking these receptors on the
dorsolateralprefrontal cortex. They may also
cause extra-pyramidal side effects such as
tremors in the hands and uncoordination by
blocking dopamine receptors on midbrain
regions, such as the caudate nucleus, which
participate in the coordination of physical activity
(Fig. 9).
A major obstacle for the medication of any
brain disorder is the blood-brain barrier which
tightly monitors the chemistry and nutrition of
the brain J=. The endothelial cells forming the
capillaries of the rest of the body are much more
loosely organized than those of the brain,
permitting diffusion of nutrients and waste
elements to and from the blood and body tissues.
The capillaries of the brain, however, are
organized in such a way that nutrients must be
actively transported across the endothelial
membrane ra. Thus is the delicate chemistry of
Dorso-Lalera
Pre-Fronlal Cortex
Neuroleptics treat the positive symptoms of Schizophrenia
by blocking a portion of the dopamine receptors in those
areas of the brain which have been made dysfunctional by
excessive dopamine stimulus. They are not selective about
which dopaminergic regions they block, however, resulting
in some undesireablo side effects.
(Fig. 8)
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Dorso-Lateral
Pre-Frontal Cortex
A mapr side effect ot extended use ol neuroleptics
is the appearance of extra-pyramidal effects,which
manifest themselves as a tremor in the hands and
extremeties. They result from blockage ol the A9
dopaminergicpathways which supply areas of the brain such as the
caudate nucleus and the putamen which .in turn, help in the coordination ofmovement All neuroleptics cause
extra-pyramidal effects with the notable exception ol clozapine which selectively blocks only the AW dopaminergicpathways
of the brain. It has not yetbeen determined why clozapine, in contrast to other drugs, selectively targets the AW pathways
Substantia
Nigra Ventral
Tegmental
Area
(Fig. 9)
Endothelial
_
Cell in Cross
Section
Neuroleptic
Molecule
crossing
endothelium
Endothelial
Membranes
(Fig. 10)
Neuroleptics
& Ligands in
Bloodstream
Lumen of
Capillary
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the brain carefully controlled. Because of this,
brain medications are severely limited by their
ability to cross this barrier. Generally,
neuroleptics and other lipid-soluble drugs cross
this barrier relatively easily (Fig. 10), whereas
water-soluble drugs have to be carefully
designed to fool this natural monitoring system
Abnormalities in expression of dopamine
receptors are also significant and may occur in
several basicways. I have seen no way in which
all of schizophrenic phenomena may be
explained in terms of receptor anomalies. It is
possible, however, that receptoranomalies play
a major role in the manifestation of the disease.
Dopamine receptors occur in basically two
types, referred to as D, and D, receptors :,\
Generally, it is known that D, stimulates cyclic
adenosine monophosphate (AMP) activity and
therefore probably increases cell metabolism
or some aspect of it, whereas D, inhibits cyclic
AMP activity and consequently is most likely to
inhibit cell metabolism, regulating the activity of
D,3'. It is known that all effective antipsychotic
drugs bind strongly to D (Fig. 11) ",
demonstrating that it is by the inhibition of this
receptor activity that neuroleptics exercise their
effect.
(Fig. 11)
(Fig. 12)
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A receptor anomaly may conceivably be a functioning of these receptors (Fig. 1 3)38. This is
genetically expressed defect (Fig. 12) whereby very similar to what happens in the disease,
one or both of the two kinds of receptors fails to myasthemia gravis. The body acquires an
function properly (is underactive oroveractive). immunity to the receptors expressed on the
This hypothesis would fail to explain the typically body's muscle tissue cellswhich receive efferent
late onset of the disease, however, unless it stimulus. Antibodies destroy these receptors,
was only the neurons of the preventing the interaction of otherwise healthy
dorsolateralprefrontal cortex or related neurons muscle and nerve tissue. The victim can no
which tended to express these hypothetically
defective receptors.
longer stimulate the affected muscle tissue and
so can no longer move his own body.
Alternatively, it is possible that the body Unstimulated muscle tissue atrophies and the
may acquire an immunity to its own dopamine victim eventually dies when the receptors that
receptors (one kind or both) and may express receive stimulus on such majormuscularorgans
antibodies which may attack and impair the as the heart, lungs, and gastrointestinal tract
are destroyed ". The shortcoming of thistheory
as applied to schizophrenia is that such a
scenario would seem to affect all areas of the
brain more or less equally whereas
schizophrenia appears to affect different areas
of the brain in different ways.
A third receptor anomaly model is advanced
by Dr. Philip Seeman of the University ofToronto
and his associates in the article, "Dopamine
receptors and transporters in Parkinson's
disease and schizophrenia", which appeared in
the July 1990 issue of The FASEB Journal. I
cannot pretend to fully understand this model. It
involves more chemistry than I can really follow
(Fig. 13)
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at this point. Basically, there is a fault (acquired studies have discovered, however, that groups
by unspecified means - probably genetically) of these neurons are misaligned in a random
in the relationship of the two receptors as fashionatanglesoffromfifteentoninetydegrees
embodied by a protein called a "second
messenger"
40. Second messenger proteins are
not exclusive to dopamine receptors. They are
causing them to synapse with neurons with
which they ordinarily would not 45. The issue,
furthermore, isn't whether or not this
the means by which all receptors manipulate disorientation occurs, but rather, how much,
the metabolism of the cell. The receptor reacts since the same phenomenonwas found to exist
to some external agent (e.g.; dopamine) which, consistently in the control subjects to a much
in turn, brings about a reaction with its second lesser degree 46.
messenger which, in its turn, reacts with the
cell's metabolism ". More recently, moreover,
An involvementforthe hippocampus would
help to explain some of the more troublesome
Dr. Seeman, et al, have demonstrated that schizophrenic phenomena. It has been found,
clozapine - a new and unusually effective for instance, that hippocampally lesioned rats
neuroleptic agent which appears to affect the
negative symptoms of schizophrenia in contrast
exhibit bizarre, repetitive behaviors during
periods of stress - such as feeding time - similar
to other neuroleptics - binds this second to those exhibited by many schizophrenic
messenger protein 42. I do not understand how patients 47.
this may affect schizophrenia, however. The hippocampus also functions extensively
More recently, schizophrenia research has in memory recall inconjunctionwiththetemporal
favored studies of hippocampal anomalies.
Several studies have demonstrated reduced
lobe (especially Wernicke's area) and the
parahippocampus 48, both of which have been
hippocampal volume among schizophrenic shown in studies to exhibit reduced volume and
patients as well as eccentric alignments of abnormal metabolism of one kind or another in
hippocampal neurons 43. Normally pyramidal schizophrenicpatients49. It has been suggested
neurons of the hippocampus and entorhinal that perhaps the voices which schizophrenic
cortex are aligned perpendicularly tothe surface patients hear in their heads may be memories
membrane or pia mater of the brain u. Recent triggered by abnormal hippocampal activity50. A
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Self Self 1 Not I
'
\
V
s
"1
Self
(Fig. 14)
more elaborate hypothesis is that, instead of
experiencing his own internal voice as his own,
a schizophrenic patient's internal monologue
may be misdirected through channels that the
brain normally reserves for "not
self"
and so it is
experienced as someone else's voice inside his
head. Probably this process would somehow
involve memory, since we immediately replay
ourownthoughts several timesaswe think51. The
difference between remembering something
as one's own words or someone else's may be
as little as the difference between one synapse
and another (Fig. 14). If those synapses occur
in the hippocampus and the neurons are
misaligned as has been demonstrated, then
this may be exactlywhat happens (although it is
most likely a good deal more complex).
This evidence and theory do not necessarily
conflictwith Dr. Weinberger's theory, but rather
elaborate on it. The A10 pathway very likely
either passes through or is mediated by the
hippocampus and the entorhinal cortex.
I recently spoke to a psychologist named,
Michael Miran, who with his wife, Esta Miran, is
proposing a model of the schizophrenic brain
which is called "homeostatic". The emphasis of
the model is the interrelationship of the parts to
create awhole. I have only recently encountered
this model and have not studied it sufficiently to
write about itwith confidence. One thing that Dr.
Miran related to me particularly caught my
interest, however. He said that normally, if you
walk into a situation that at first inspection
causes alarm, but upon closer inspection is
something that you can identify as non-
threatening, that second inspection is your
19 Franz Sugarman :
dorsolateralprefrontal cortex exercising an
inhibition reaction on your limbic system. The
example he used was that if you walk into a
room with astuffed lion in it anddon't immediately
identify that it is stuffed, you will react with alarm
- your hair will rise, your pulse will rise, etc.
When you realize that it is stuffed, your
dorsolateralprefrontal cortex exercises an
inhibiting action on your limbic system to calm
you down, manifested internally as you tell
yourself, "Oh - it's all right - it's just a stuffed
lion."
According to Dr. Miran, what happens to
the schizophrenic patient is that dopaminergic
and adrenergic tracts to the
dorsolateralprefrontal cortex become
overstimulated and the dorsolateralprefrontal
cortexkindof "locksup". Thus, itfailstoexercise
its inhibiting effect on the limbic system.
Furthermore, this "lock
up" is a kind of
overstimulation which
"overflows"
to nearby
areas of the brain, stimulating the temporal lobe
and activating memories stored there.
Consequently, when confronted with the stuffed
lion, the response of the schizophrenic patient
is not mediated by the dorsolateralprefrontal
cortex, resulting in continued alarm with
accompanying confusion, halluciations and
delusion.
Drs. Esta and Michael Miran haveusedthis
model as the basis for a program of therapy
which has shown a high rate of success. A key
element of their program is that they treat the
patient as brain-injured, rather than
psychologically disturbed. While not aimed at
curing the schizophrenic patient, the Inside/
Outside Program has shown great effectiveness
in reeducating schizophrenicpatientspermitting
them to better cope with the outside world 52.
At this point, I have constructed my own
model of schizophrenia, based on all the different
theories and studies I've sampled. First of all,
an embryologic malformation occurs in the
hippocampus and/or entorhinal cortex, perhaps
due to genetic defect, anoxia (prenatal oxygen
deprivation) or maybe due to a viral infection
contracted during the second trimester of
pregnancy 53. The condition manifests itself later
on in adulthood only as normal development
brings the dorsolateralprefrontal cortex to
maturity 54. It is the strain of having this last area
in operation, perhaps along with unusual stress
(onset of schizophrenia is frequently associated
with periods of high stress 55),which overloads
the malformed areas 56. Failure of the
hippocampus, etc., to regulate stimulus to the
dorsolateralprefrontal cortex causes the
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dysfunction of that area and consequently
negative symptomology. It is likely that there is
aGABAergic tractwhich normally runs back to
thehippocampusfromthedorsolateralprefrontal
cortex and actsto inhibit dopaminergic stimulus
to the limbic system and midbrain from the
hippocampus. It has been demostrated that
schizophrenic patients exhibit reduced GABA
(gamma-amino-butyric acid - a major
neurotransmitter in the brain which functions
mainly as an inhibitor of dopamine tracts, but is
likely to have other functions as well 57) levels in
the hippocampus which has been in turn
associated with higher dopamine
levels in the amygdala . Dysfunction of the
dorsolateralprefrontal cortex, in turn, causes
dysfunction of this GABAergic tract. Limbic
function is nomally regulated by hippocampal
dopaminergic stimulus. That stimulus is, in turn,
regulated in part by this inhibitory GABAergic
stimulus from the dorsolateralprefrontal cortex.
Dopaminergic overstimulus of limbic and
midbrain regions accounts for emotional
instability, agitation, and other positive
symptoms, while hippocampal dysfunction and
overstimulation causes activation of memories
and perception of voices as discussed on page
seventeen59.
PART III
Illustration ofmy thesis broke into four parts.
The central illustrationwas a series ofAdobe
Illustrator 3.0 images (Figs. 1-9) describing Dr.
Weinberger's theory as described in his article
which appeared in the July 1987 issue of
Archives of General Psychiatry as mentioned
earlier. These were created by scanning a
photo of a brain sagital section from pgs. 43, 69
and 79, of Atlas of the Human Brain in Section.
by Melville Roberts, B.S., M.D., and Joseph
Hanaway, A-B-.M-D60. Using it as a template, I
traced it manually and added graphics.
As a reference for the A10 dopaminergic
pathways, I used illustrations from a publication
by Dr. Dave Felton and John R. Sladek, Jr. of
pathways reported to exist in monkeys 6I. I took
considerable liberties in extrapolatingwhat paths
these projectionsmight take inthe human brain.
I did, however, consult with Dr. Lamberti of
Strong Memorial Hospital as to the probable
accuracy of my illustrations.
As a tangent to Dr. Weinberger's theory, I
went into further detail in my description of the
means by which a receptor anomaly might
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printer.
The fourth section of my exhibit was an
animated piece generated in Macromind
Director 2.0. It was derived from my original set
of Adobe Illustrator 3.0 pieces and did not differ
from it significantly in content. The onlydifference
was that it more explicitly demonstrated the
time element with animation. The imagery lost
some of the clarity of the original Adobe Illustrator
3.0 pieces because itwas necessary to translate
them into a pixilated PICT image format in order
to get them into Macromind Director 2.0.
I chose to stick entirely to the computer as
my medium because, in the first place, I believe
that it was in my own best interest to develop
these skills, as they are likely to be most in
demand in the future. Secondly, the computer
allowed me to execute what looked like final
pieces to show the people I was consulting
with,and yet allowed me to change a great deal
if I needed to without ruining the piece. Also, I
was able to save my steps along the way if I
needed to back up to an earlier stage of the
illustration. In the third place, it allowed me to
repeat an image several times for several
different illustrations or within the same
illustration without having to redraw it over and
over again.
I particularly enjoyed using the Adobe
Photoshop 1 .0 airbrush function which allowed
me to get effects similar to what might be
expected with an airbrush, but with much more
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occur. In contrast to the previous set of
neuroanatomical schematic images this set of
images was meant to describe the possible
pathogenesis of schizophrenia at a cellular
level in a more realistic manner. I took this
approach because it seemed to me that, most
illustration of celllular neurological activity has
been executed in a highly abstract and
schematic manner. A more realistic, colorful,
three-dimensional set of illustrations of the neural
cell environment might bring more interest,
excitement, and understanding to the field. To
achieve this, I used a combination of programs.
I started the initial drawing in Adobe Illustrator
(Macintosh version 3.0, Copyright 1987-90
Adobe Systems Incorporated) and then
transferred that image to Adobe Photoshop
(Macintosh version 1.0, Copyright 1989-90
Adobe Systems Incorporated) where, using a
combination of fills and patterns and filters, I
created texture and three-dimensionality (Fig.
15). At times, I also used Macromind Director
(Macintosh version 2.0, Copyright 1 990 Adobe
Systems Incorporated) because I preferred
some aspects of its fill function.
The third section of my exhibitwas similarin
form anddescribedthe distribution of neuroleptic
medication particularly through the blood-brain
barrier. One of the illustrations from this section
provided source material for all the rest of the
Adobe Photoshop 1 .0 images I created. That
image was generated, as described before, by
initially creating drawings in Adobe Illustrator
3.0 and then transporting them to Adobe
Photoshop 1.0 where I manipulated them and
overlaid them in layers into my final illustration
(Fig. 16). Background imagery for my other
illustrations, however, was derived from this
image by copying an approximately one-half
inch to one inch square section and enlarging it
to suit my purposes (Figs. 10-13, 15 and 17). I
then refined the image using various filter
functions and by drawing into it.
The distortions and accidents brought about
by the enlargement and filtration process created
an almost painterly textural feel, unattainable
by any other computer procedure. I then added
any remaining elements I might desire drawn in
Adobe Illustrator 3.0.
All my Adobe Illustrator 3.0 pieces and
those of my Adobe Photoshop 1.0 images
which exceeded 8.5x11 inch dimensionswere
printed by a thermal wax transfer process on
a QMS colorscript 100 printer. The remainder
of theAdobe Photoshop 1 .0 pieces were printed
through a dye process on a Kodak XL 7700
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ease of correction and without the hassle of
having to cut frisket.
My initial research into this subject matter
was poorly directed. There are many
complicated and conflicting theories regarding
schizophrenia, and it is very difficultforsomeone
with limited medical education such as myself
to knowwhere to start. Consequently, I believe
much of my research time was wasted until I
finally consulted with Dr. Lamberti of Strong
Memorial Hospital, only about four months
before my opening. Dr. Lamberti's enthusiasm
and helpwere critical to getting me going on the
right track with a theory that at once made
sense and lent itself to illustration.
Schizophrenia is adiseasewhich continues
to be a subject of lively debate among
researchers. Little of a concrete nature is really
known about it. This has strongly affected my
project, at once to my advantage and
disadvantage. It has made things more difficult
insofarasthere is not acentral body of evidence
and theory agreed upon by the psychiatric and
neurological community to work from. It has
caused me to have to deal with the question of
what to illustrate almost as much as how to
illustrate it. As a professional illustrator, my job
should be to help make the subject
understandable ratherthan to judge the relative
value of different theories.
The advantage has been that I have become
involved in an exciting, growing area of research
close to the ground floor. My unusual
specialization may give me the research-
oriented job opportunities I am really hoping for.
It has also allowed me to explore an area that
has been of great personal interest to me, since
several people I have known have become
schizophrenic or have schizophrenic relatives.
It was helpful to be able to connect the
observations made by researchers with my
own experience of schizophrenic patients. I
think that this project has helped me achieve a
much greater understanding of how these
people are afflicted.
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